China Shineway Pharmaceutical Group (2877.HK) Earnings Analysis
China Shineway Pharmaceutical Group (2877.HK) next reports earnings on 2026-09-01. Trailing P/E 5.68.
Last updated 2026-07-23 · Source: FMP fundamentals + earnings calendar (company filings); consensus from sell-side analyst grades
When does 2877.HK next report earnings?
| Next earnings date | 2026-09-01 |
|---|---|
| Consensus EPS estimate | n/a |
| Revenue estimate | n/a |
2877.HK earnings history — beats and misses
| Quarter (report date) | EPS actual | EPS est. | Surprise | Result |
|---|---|---|---|---|
| 2026-03-27 | 0.4895 HKD | n/a | n/a | n/a |
| 2025-08-27 | 0.89 HKD | n/a | n/a | n/a |
| 2024-08-29 | 0.891 HKD | n/a | n/a | n/a |
2877.HK valuation and analyst view
| Trailing P/E | 5.68 |
|---|---|
| Trailing EPS | 1.258 HKD |
| Price / book | 0.67 |
| Dividend yield | 7.38% |
| Market cap | 6.22B |
Limited or no published sell-side analyst coverage for this symbol.
Related research pages
Frequently asked questions
When is China Shineway Pharmaceutical Group (2877.HK)'s next earnings date?
China Shineway Pharmaceutical Group is next scheduled to report on 2026-09-01.
Did 2877.HK beat earnings last quarter?
Consensus estimate data was not available for 2877.HK's 2026-03-27 report.
What is 2877.HK's current P/E ratio and EPS?
2877.HK trades at a trailing P/E of 5.68 on trailing EPS of 1.257540361653378 HKD.
What do analysts rate 2877.HK?
2877.HK has limited or no published sell-side analyst coverage in our dataset, so no consensus rating is shown. Fundamentals and earnings history above are sourced from company filings via FMP.